Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Careers and Recruitment
  • Published:

Back to the beginning

Nature volume 461, pages 434–435 (2009)Cite this article

Some think Osaka can once again be a centre for the biosciences industry. David Cyranoski calculates the odds.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. David Cyranoski is Nature's Asian correspondent.,

    David Cyranoski

Authors
  1. David Cyranoski
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Primed for a biotech boom

Scientists & Societies

Related external links

Osaka University

Chugai Pharmaceutical

National Institute of Biomedical Innovation

Shionogi

AnGes

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cyranoski, D. Back to the beginning. Nature 461, 434–435 (2009). https://doi.org/10.1038/nj7262-434a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nj7262-434a

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing